Literature DB >> 15264274

Unravelling the genetics of prostate cancer.

Stephen M Edwards1, Rosalind A Eeles.   

Abstract

This review describes what is currently known about the genetics of prostate cancer. Traditionally, the genetics of a suspected inherited cancer predisposition have generally been thought of in terms of a single, high-risk gene with a dominant mode of inheritance. Such a gene might be observed in families, as has been documented in familial breast cancer (BRCA1/2), familial colorectal cancer (HNPCC), retinoblastoma (RB1), and Wilms tumor (WT1). This review investigates the evidence for the existence, first of familial prostate cancer, and second, for the presence of such a high-risk gene in those families by epidemiological and experimental approaches. Another current area of interest in prostate cancer is the investigation of the contribution of common lower penetrance genes to the disease. This alternative approach has become popular, as it raises the issue of frequently seen genetic variations such as single nucleotide polymorphisms (SNPs) having relevance to the risk of developing the disease. Finally, this article will explore the way forward, with emphasis on worldwide collaboration from teams attempting to find the genes responsible for the disease and investment in new technologies that will aid in their discovery. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15264274     DOI: 10.1002/ajmg.c.30027

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  23 in total

Review 1.  Identification of new genetic risk factors for prostate cancer.

Authors:  Michelle Guy; Zsofia Kote-Jarai; Graham G Giles; Ali Amin Al Olama; Sarah K Jugurnauth; Shani Mulholland; Daniel A Leongamornlert; Stephen M Edwards; Jonathan Morrison; Helen I Field; Melissa C Southey; Gianluca Severi; Jenny L Donovan; Freddie C Hamdy; David P Dearnaley; Kenneth R Muir; Charmaine Smith; Melisa Bagnato; Audrey T Ardern-Jones; Amanda L Hall; Lynne T O'Brien; Beatrice N Gehr-Swain; Rosemary A Wilkinson; Angela Cox; Sarah Lewis; Paul M Brown; Sameer G Jhavar; Malgorzata Tymrakiewicz; Artitaya Lophatananon; Sarah L Bryant; Alan Horwich; Robert A Huddart; Vincent S Khoo; Christopher C Parker; Christopher J Woodhouse; Alan Thompson; Tim Christmas; Chris Ogden; Cyril Fisher; Charles Jameson; Colin S Cooper; Dallas R English; John L Hopper; David E Neal; Douglas F Easton; Rosalind A Eeles
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

2.  Cyclooxygenase 2 genotypes influence prostate cancer susceptibility in Japanese Men.

Authors:  Satoru Sugie; Hiromasa Tsukino; Shoichiro Mukai; Takahiro Akioka; Norihiko Shibata; Masafumi Nagano; Toshiyuki Kamoto
Journal:  Tumour Biol       Date:  2013-11-08

Review 3.  A genetic-based approach to personalized prostate cancer screening and treatment.

Authors:  Brian T Helfand; William J Catalona; Jianfeng Xu
Journal:  Curr Opin Urol       Date:  2015-01       Impact factor: 2.309

4.  Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score.

Authors:  Brian T Helfand; Haitao Chen; Richard J Fantus; Carly A Conran; Charles B Brendler; Siquan Lilly Zheng; Patrick C Walsh; William B Isaacs; Jianfeng Xu
Journal:  Prostate       Date:  2018-06-19       Impact factor: 4.104

5.  Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations.

Authors:  Matthew Cossack; Cameron Ghaffary; Patrice Watson; Carrie Snyder; Henry Lynch
Journal:  J Genet Couns       Date:  2013-07-25       Impact factor: 2.537

Review 6.  Molecular markers in prostate cancer. Part I: predicting lethality.

Authors:  Sachin Agrawal; William D Dunsmuir
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

7.  Mutation analysis of the MSMB gene in familial prostate cancer.

Authors:  Z Kote-Jarai; D Leongamornlert; M Tymrakiewicz; H Field; M Guy; A A Al Olama; J Morrison; L O'Brien; R Wilkinson; A Hall; E Sawyer; K Muir; F Hamdy; J Donovan; D Neal; D Easton; R Eeles
Journal:  Br J Cancer       Date:  2009-12-08       Impact factor: 7.640

8.  Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

Authors:  S M Edwards; D G R Evans; Q Hope; A R Norman; Y Barbachano; S Bullock; Z Kote-Jarai; J Meitz; A Falconer; P Osin; C Fisher; M Guy; S G Jhavar; A L Hall; L T O'Brien; B N Gehr-Swain; R A Wilkinson; M S Forrest; D P Dearnaley; A T Ardern-Jones; E C Page; D F Easton; R A Eeles
Journal:  Br J Cancer       Date:  2010-08-24       Impact factor: 7.640

9.  Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.

Authors:  Zsofia Kote-Jarai; Douglas F Easton; Janet L Stanford; Elaine A Ostrander; Johanna Schleutker; Sue A Ingles; Daniel Schaid; Stephen Thibodeau; Thilo Dörk; David Neal; Jenny Donovan; Freddie Hamdy; Angela Cox; Christiane Maier; Walter Vogel; Michelle Guy; Kenneth Muir; Artitaya Lophatananon; Mary-Anne Kedda; Amanda Spurdle; Suzanne Steginga; Esther M John; Graham Giles; John Hopper; Pierre O Chappuis; Pierre Hutter; William D Foulkes; Nancy Hamel; Claudia A Salinas; Joseph S Koopmeiners; Danielle M Karyadi; Bo Johanneson; Tiina Wahlfors; Teuvo L Tammela; Mariana C Stern; Roman Corral; Shannon K McDonnell; Peter Schürmann; Andreas Meyer; Rainer Kuefer; Daniel A Leongamornlert; Malgorzata Tymrakiewicz; Jo-Fen Liu; Tracy O'Mara; R A Frank Gardiner; Joanne Aitken; Amit D Joshi; Gianluca Severi; Dallas R English; Melissa Southey; Stephen M Edwards; Ali Amin Al Olama; Rosalind A Eeles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

10.  Concordant colon tumors in monozygotic twins previously treated for prostate cancer.

Authors:  Arnoud Templeton; Giancarlo Marra; Emanuele Valtorta; Karl Heinimann; Hansjakob Müller; Dieter Köberle; Silke Gillessen
Journal:  Fam Cancer       Date:  2008-11-16       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.